The Role of Clarithromycin (Klaracid) In the Treatment Of Community Acquired Chest Infection.
Main Article Content
Chest infection are common and can be potentially serious if not treated in time. The development of infection are normally prevented by pulmonary defence mechanism. Major pathogens associated with community acquired chest infections include streptococcus pneumonae, hemophilus influenza and mycoplasma pneumonae. Standard treatment is with penicillin derivative or erythomicin. Clarithomycin is a new macrolide antibiotic with extended activity against many of the pathogens associated with chest infection. Addition of new antibiotics is always welcomebecause of the emergency of resistant strains.
How to Cite
Khan MA, Shah SM, Saeedi MI. The Role of Clarithromycin (Klaracid) In the Treatment Of Community Acquired Chest Infection. J Postgrad Med Inst [Internet]. 2011 Aug. 25 [cited 2023 May 31];7(2). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/429
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.